1.2.2016
EN
Official Journal of the European Union
C 38/58
Order of the General Court of 2 December 2015 — Novartis v OHIM– Mabxience (HERTIXAN)
(Case T-41/15) (1)
((Community trade mark - Opposition proceedings - Withdrawal of application for registration - No need to adjudicate))
(2016/C 038/77)
Language of the case: Spanish
Parties
Applicant: Novartis AG (Basel, Switzerland) (represented by: M. Douglas, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: S. Palmero Cabezas, Agent)
Other party to the proceedings before the Board of Appeal of OHIM: Mabxience SA (Montevideo, Uruguay)
Re:
Action brought against the decision of the First Board of Appeal of OHIM of 31 October 2014 (Case R 2550/2013-1) relating to opposition proceedings between Novartis AG and Mabxience SA.
Operative part of the order
1.
There is no need to adjudicate on the action.
2.
Novartis AG is ordered to pay the costs.
(1) OJ C 107, 30.3.2015.
Full & Egal Universal Law Academy